Two types of unsafe drinker judged to have metabolic syndrome: Typical metabolic syndrome or alcohol-related syndrome?

Medical Science Monitor

Volumn 15, Issue 6, 2009, Pages

  Yokoyama, Hirokazu ^a   Hirose, Hiroshi ^a   Saito, Ikuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Adiponectin; Alcohol drinking; ALT AST; Metabolic syndrome; Obesity

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CALCIUM; HEMOGLOBIN; URIC ACID;

ADULT; AGED; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL RELATED METABOLIC SYNDROME; ALCOHOLISM; ARTICLE; BODY MASS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRINKING BEHAVIOR; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE;

ADIPONECTIN; ADULT; AGED; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ASPARTATE AMINOTRANSFERASES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SAFETY;

EID: 66749129244     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Vega GL: Obesity, the metabolic syndrome, and cardiovascular disease. Am Heart J, 2001; 142: 1108-1116 (Pubitemid 33131824)
2. Eckel RH, Grundy SM, Zimmert PZ: The metabolic syndrome. Lancet, 2005; 365: 1415-1428 (Pubitemid 40523737)
3. Alberti K, Zimmet P: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998; 15: 539-553
4. Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med, 1998; 16: 442-443
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497
6. International Diabetes Federation The IDF consensus worldwide definition of the metabolic syndrome http://www.idf.org/webdata/docs/Metac-syndrome-def. pdf, 2005
7. Mezey E: Metabolic effects of alcohol. Fed Proc, 1990; 44: 134-138 (Pubitemid 15125522)
8. Chait A, Brunzell JD: Acquired hyperlipidemia (secondary dyslipoproteinemias) Endocrinol Metab Clin North Am, 1900; 19: 259-278
9. Cauley JA, Kuller LH, LaPorte RE et al: Studies on the association between alcohol and high density lipoprotein cholesterol: possible benefits and risks. Adv Alcohol Subst Abuse, 1987; 6: 53-67 (Pubitemid 17134245)
10. Ryan K: Alcohol and blood sugar disorders; an overview. Alcohol Health Res World, 1983; 8: 3-15
11. Kaysen G, North RH: The effect of alcohol on blood pressure and electrolytes. Med Clinics North America, 1988; 68: 221-246
12. The Japanese Ministry of Welfare and Labor (in Japanese); http://www.kenkounippon21.gr.jp/kenkounippon21/about/kakuron/index.html
13. Yokoyama H, Hirose H, Ohgo H et al: Effects of excessive ethanol consumption on the diagnosis of the metabolic syndrome using its clinical diagnostic criteria. Int Med, 2007; 46: 1345-1352 (Pubitemid 47455756)
14. Suter PM: Is alcohol consumption a risk factor for weight gain and obesity? Crit Rev Clin Lab Sci, 2005; 42: 197-227
15. Lukasiewicz E, Mennen LI, Bertrais S et al: Alcohol intake in relation to body mass index and waist-to-hip ratio: the importance of type of alcoholic beverage. Clin. Nutri, 2005; 8: 315-320
16. Lieber CS: Alcohol and the liver. Hepatology, 1984; 4: 1243-1260
17. Miller PM, Anton RF, Egan BM et al: Excessive alcohol consumption and hypertension: clinical implications of current research. J. Clin. Hypertens. (Greenwich), 2005; 6: 346-351
18. Apte MV, Wilson JS: Alcohol-induced pancreatic injury. Best Pract Res Clin Gastroenterol, 2003; 17: 593-612 (Pubitemid 37554736)
19. Matsuzawa Y: Metabolic syndrome-definition and diagnostic criteria in Japan J Atheroscler Thromb, 2005; 12: 301
20. Hoffmann RG: New Clinical Laboratory Standardization Methods. Exposition Press, New York, 1974
21. Conigrave KM, Saunders JB, Whitfield JB: Diagnostic tests for alcohol consumption. Alcohol Alcohol, 1995; 30: 13-26
22. Montalt N, Bean P: Use of contemporary biomarkers in the detection of chronic alcohol use. Med Sci Monit, 2003; 9: 285-290
23. Harasymiw J, Bean P: The early detection of alcohol consumption (EDAC) test shows better performance than Gamma-glutamyltransferase (GGT) to detect heavy drinking in a large population of males and females. Med Sci Monit, 2007; 13(9): PI19-24 (Pubitemid 47416703)
24. Kim S, Moustaid-Moussa N: Secretory, endocrine and autocrine /paracrine function of the adipocyte. J Nutr, 2000; 130: 3110S-15S (Pubitemid 32005351)
25. Yamamoto Y, Hirose H, Saito I et al: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond), 2002; 103: 137-142
26. Jiang J, Torok N: Nonalcoholic steatohepatitis and the metabolic syndrome. Metab Synd Rel Dis, 2008; 6: 1-8
27. Hannuksela ML, Ramet ME, Nissinen AE et al: Effects of ethanol on lipids and atherosclerosis. Phathophysiology, 2004; 10: 93-103
28. Sharpe PC, McBride R, Archbold GP: Biochemical markers of alcohol abuse. QJM, 1996; 89: 137-144 (Pubitemid 26053127)
29. Avogaro A, Sambataro M, Marangoni A et al: Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor alpha. J Endocrinol Invest, 2003; 26: 1213-1218 (Pubitemid 38324740)
30. Sierksma A, Patel H, Ouchi N et al: Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care, 2004; 27: 184-189 (Pubitemid 38196730)
31. Beulens JW, van Loon LJ, Kok FJ et al: The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: a human intervention study. Diabetologia, 2007; 50: 1388-9232. (Pubitemid 46879023)
32. Sorbi D, Boynton J, Lindor KD: The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol, 1999; 94: 1018-1022 (Pubitemid 29173621)
33. Nomura F, Ohnishi K, SatomuraY et al: Liver function in moderate obesity- study in 534 moderately obese subjects among 4613 male company employees. Int J Obes, 1986; 10: 349-354 (Pubitemid 17182278)
34. Demori L, Voci A, Fugassa E, Burlando B: Combined effects of high-fat diet and ethanol induce oxidative stress in rat liver. Alcohol, 2006; 40: 185-191 (Pubitemid 46528100)
35. Genser B, Marz W: Low density lipoprotein cholesterol, statins and cardiovascular events: a meta-analysis. Clin Res Cardiol, 2006; 95: 393-404 (Pubitemid 44133990)
36. Leikert JF, Räthel TR, Wohlfart P et al: Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation, 2002; 24: 1614-1617
37. Fan AZ, Russell M, Naimi T et al: Patterns of alcohol consumption and the metabolic syndrome. J Clin Endocrinol Metab, 2008; (in press)
38. Athyros VG, Liberopoulos EN, Mikhailidis DP et al: Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology, 2007; 58: 689-697